Market revenue in 2024 | USD 4,109.4 million |
Market revenue in 2030 | USD 6,547.9 million |
Growth rate | 8.3% (CAGR from 2025 to 2030) |
Largest segment | Continuous blood glucose monitoring system |
Fastest growing segment | Smart insulin pens |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Smart glucose meter, Continuous blood glucose monitoring system, Smart insulin pens, Smart Insulin Pumps/Closed Loop Systems, Apps |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital diabetes management market will help companies and investors design strategic landscapes.
Continuous blood glucose monitoring system was the largest segment with a revenue share of 43.18% in 2024. Horizon Databook has segmented the Europe digital diabetes management market based on smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps/closed loop systems, apps covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of diabetes and growing awareness about diabetes management & control are among the key factors expected to propel the market over the forecast period. The Russian Federation, Germany, Turkey, Spain, and Italy are the top five countries in the European region with a high incidence of diabetes.
Europe held a significant market share in the global digital diabetes management market, being the second-largest market after North America. This can be primarily attributed to the presence of major players in the region.
New product launches and the implementation of better reimbursement policies are expected to propel the market. In September 2019, Medtronic launched the Envision Pro CGM system, a fully disposable, zero-calibration professional CGM system.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe digital diabetes management market, including forecasts for subscribers. This continent databook contains high-level insights into Europe digital diabetes management market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account